6A,6B,6C,6D,6E,6F,6G-HEPTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,6F,6G-HEPTATHIO-.BETA.-CYCLODEXTRIN
UNII 7FS7DBU37D

Substance Identification & Data

This profile provides standardized clinical and technical data for 6a,6b,6c,6d,6e,6f,6g-heptakis-s-(2-carboxyethyl)-6a,6b,6c,6d,6e,6f,6g-heptathio-.beta.-cyclodextrin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7FS7DBU37D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 731769-20-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7FS7DBU37D

CAS Registry Number

731769-20-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

6A,6B,6C,6D,6E,6F,6G-HEPTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,6F,6G-HEPTATHIO-.BETA.-CYCLODEXTRIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C63H98O42S7

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JOJXASVGXFBFNR-JUWBGTNNSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

11051554

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(SCCC(O)=O)[C@@H]1[C@]2(O[C@]3(O[C@H](CSCCC(O)=O)[C@]([C@H](O)[C@H]3O)(O[C@]4(O[C@H](CSCCC(O)=O)[C@]([C@H](O)[C@H]4O)(O[C@]5(O[C@H](CSCCC(O)=O)[C@]([C@H](O)[C@H]5O)(O[C@]6(O[C@H](CSCCC(O)=O)[C@@](O[C@]7(O[C@H](CSCCC(O)=O)[C@@](O[C@]8(O[C@H](CSCCC(O)=O)[C@@](O[C@@](O1)([C@H](O)[C@H]2O)[H])([C@H](O)[C@H]8O)[H])[H])([C@H](O)[C@H]7O)[H])[H])([C@H](O)[C@H]6O)[H])[H])[H])[H])[H])[H])[H])[H])[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 6a,6b,6c,6d,6e,6f,6g-heptakis-s-(2-carboxyethyl)-6a,6b,6c,6d,6e,6f,6g-heptathio-.beta.-cyclodextrin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

.BETA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,6F,6G-HEPTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,6F,6G-HEPTATHIO-

6A,6B,6C,6D,6E,6F,6G-HEPTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,6F,6G-HEPTATHIO-.BETA.-CYCLODEXTRIN

Systematic Nomenclature

3-(((1S,3S,5S,6S,8S,10S,11S,13S,15S,16S,18S,20S,21S,23S,25S,26S,28S,30S,31S,33S,35S,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-10,15,20,25,30,35-HEXAKIS(2-CARBOXYETHYLSULFANYLMETHYL)-36,37,38,39,40,41,42,43,44,45,46,47,48,49-TETRADECAHYDROXY-2,4,7,9,12,14,17,19,22,24,27,29,32,34-TETRADECAOXAOCTACYCLO(31.2.2.23,6.28,11.213,16.218,21.223,26.228,31)NONATETRACONTAN-5-YL)METHYLSULFANYL)PROPANOIC ACID

SYS

External Clinical & Regulatory Resources

Previous UNII7FS6H939K6

Next UNII7FS7YK4YAF